Výsledky vyhledávání - "Carol Farhangfar"

Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer

Autor: Joel R. Eisner, Kirk D. Beebe, Gregory M. Mayhew, Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M. Uronis, Jill Mooney, Michael V. Milburn, David Foureau, Richard L. White, Asim Amin, Marcos E. Milla

Publikováno v: Cancer Research Communications. 2:894-903

Recombinant human high-dose IL2 (HD-IL2; aldesleukin) was one of the first approved immune-oncology agents based upon clinical activity in renal cell carcinoma (RCC) and metastatic melanoma but use was limited due to severe toxicity. Next-generation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3af86004040503294c91ba86fa069a5e
https://doi.org/10.1158/2767-9764.crc-21-0153

Zobrazit plný text záznamu

Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer - The Piedmont Study

Autor: Joel R. Eisner, Gregory M. Mayhew, James M. Davison, Kirk D. Beebe, Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M. Uronis, Jeffrey M. Conroy, Michael V. Milburn, David Neil. Hayes, Kathryn F. Mileham

Publikováno v: Clinical Cancer Research.

Purpose: The Piedmont study is a prospectively designed retrospective evaluation of a new 48-gene antifolate response signature (AF-PRS) in patients with locally advanced/metastatic NS-NSCLC treated with pemetrexed-containing platinum doublet chemoth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::43c4953b0bb03f5b73d0ac32e56d115c
https://doi.org/10.1158/1078-0432.ccr-22-2558

Zobrazit plný text záznamu

Data from Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer

Autor: Marcos E. Milla, Asim Amin, Richard L. White, David Foureau, Michael V. Milburn, Jill Mooney, Joshua M. Uronis, Farhang Farhangfar, Carol Farhangfar, Yuelong Guo, Yoichiro Shibata, Gregory M. Mayhew, Kirk D. Beebe, Joel R. Eisner

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aee2f498634f181e0903dde0904d827
https://doi.org/10.1158/2767-9764.c.6550872.v1

Zobrazit plný text záznamu

Supp Table test from Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer

this is a test

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dcd889514c515c62aa335b1a1f130c0
https://doi.org/10.1158/2767-9764.22545183

Zobrazit plný text záznamu

Table S1 and Table S2 from Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer

40 gene IL-2 response classifier and related immune cell types

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e912be1d5a6174fc4d7074ca2edfe78
https://doi.org/10.1158/2767-9764.22545180

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání